文献速递泌尿生殖与妇科肿瘤放疗

COVID-19对妇科肿瘤诊疗的影响:美国执业妇科放射肿瘤医师调查

Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United States.
PubMed 文献 · Adv Radiat Oncol · 2023-02-26

该研究对美国96名具有妇科肿瘤诊治经验的放射肿瘤医师进行匿名在线调查,49%回复。结果显示,56%报告局部晚期宫颈癌增加;66%报告手术管理暂停,最常见持续1至3个月;短程近距离放疗使用增加;61%照料过至少1例COVID-19阳性患者;45%报告因COVID-19阳性暂停或延迟治疗;55%报告患者因COVID-19相关担忧自行延迟就医;33%观察到宫颈癌总治疗时间超过8周。

要点

  • 56%的受访医师报告局部晚期宫颈癌增加,子宫内膜癌、外阴癌或阴道癌未见类似增加。
  • 66%报告手术管理暂停,其中61%报告暂停持续1至3个月;疫情期间短程近距离放疗使用增加。
  • 45%报告因COVID-19阳性暂停或延迟治疗,55%报告患者因COVID-19相关担忧自行延迟就医。

核心结论

  • 这项前瞻性收集的匿名执业模式调查数据显示,COVID-19疫情导致启动治疗延迟、近距离放疗疗程缩短,以及报告初诊时局部晚期宫颈癌病例增加。
  • 这些数据可作为自我评估手段,以确保在COVID-19地方性流行阶段为妇科患者做出适当决策。

研究设计与样本

  • 创建匿名在线调查,发放给预先确定的美国具有妇科患者管理临床专长的放射肿瘤医师。
  • 调查包括人口学问题,随后为评估COVID-19疫情相关特定诊疗模式的有向问题。
  • 96名受邀放射肿瘤医师中47名回复,回复率为49%。

主要发现

  • 56%的受访者报告局部晚期宫颈癌增加,子宫内膜癌、外阴癌或阴道癌患者未见类似增加。
  • 多数受访者(66%)报告手术管理暂停,持续时间以1至3个月最常见(61%)。
  • 报告疫情期间短程近距离放疗方案使用增加。
  • 多数提供者(61%)报告照料过至少1例COVID-19检测阳性患者。
  • 45%的受访者报告因COVID-19阳性暂停或延迟治疗,55%报告患者因COVID-19相关担忧选择延迟自身诊疗。

临床怎么用

  • 原文未据此给出推荐。
  • 作者指出这些数据可作为自我评估手段,以确保在COVID-19地方性流行阶段为妇科患者做出适当决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The COVID-19 pandemic has placed demands and limitations on the delivery of health care. We sought to assess the effect of COVID-19 on the delivery of gynecologic oncologic care from the perspective of practicing radiation oncologists in the United States. METHODS AND MATERIALS: An anonymous online survey was created and distributed to preidentified radiation oncologists in the United States with clinical expertise in the management of gynecologic patients. The survey consisted of demographic questions followed by directed questions to assess specific patterns of care related to the COVID-19 pandemic. RESULTS: A total of 47 of 96 invited radiation oncologists responded to the survey for a response rate of 49%. Fifty-six percent of respondents reported an increase in locally advanced cervical cancer with no similar increase for endometrial, vulvar, or vaginal patients. Most respondents (66%) reported a pause in surgical management, with a duration of 1 to 3 months being most common (61%). There was a reported increased use of shorter brachytherapy regimens during the pandemic. Most providers (61%) reported caring for at least 1 patient with a positive COVID-19 test. A pause or delay in treatment due to COVID-19 positivity was reported by 45% of respondents, with 55% reporting that patients chose to delay their own care because of COVID-19-related concerns. Total treatment times >8 weeks for patients with cervical cancer were observed by 33% of respondents, but occurred in >25% of patients. CONCLUSIONS: Data from this prospectively collected anonymous survey of practice patterns among radiation oncologists reveal that the COVID-19 pandemic resulted in delays initiating care, truncated brachytherapy treatment courses, and a reported increase in locally advanced cervical cancer cases at presentation. These data can be used as a means of self-assessment to ensure appropriate decision making for gynecologic patients during the endemic phase of COVID-19.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Brower JV, Rhodes SS, Remick JS, et al. Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United States. Adv Radiat Oncol. 2023. PMID: 36974086. doi:10.1016/j.adro.2023.101188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。